Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- University of Iowa
- Study ID
- NCT06127264
- Status
- Recruiting
Conditions
- Ankle Foot Orthosis (AFO)
- Healthy
- Peripheral Neuropathy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- Carbon Fiber Custom Dynamic Orthosis (CDO) — DEVICEThe carbon fiber custom dynamic orthosis (CDO) will consist of a semi-rigid carbon fiber footplate, a carbon fiber posterior strut, and a proximal cuff that wraps around the leg below the knee that is fastened to different tightness's
Study Details
The primary purpose of this research study is to determine if forces within carbon fiber custom dynamic orthoses (CDOs) can be reliability assessed using Loadpad and Loadsol force measuring sensors (Novel GMBH, St. Paul, MN). An improved understanding of the forces acting within orthoses may help to guide future orthosis related research studies, provision methods, and patient education. Study participants will consist of three groups; 1) healthy, able-bodied adult participants using generic sized CDOs, which consist of a proximal cuff that wraps around the leg just below the knee, a posterior carbon fiber strut that runs the length of the leg and bends to store and return energy, and a semi-rigid footplate that acts as a lever arm to bend the posterior strut, 2) individuals without peripheral neuropathy who use AFO(s) regularly, and 3) individuals with peripheral neuropathy who use AFO(s) regularly. . Group 1 participants will be asked to fasten the proximal cuff to a self-selected cuff tightness 'SSCT', as well as three different predefined force levels; 'Loose' where the proximal cuff is loosely fastened around the participants leg, 'Moderate' where the proximal cuff is fastened with moderate tightness, and 'Tight' where the proximal cuff is tightly fastened around the participants leg. Testing in the predetermined force levels (Loose, Moderate, Tight) will occur in a randomized order. Group 2 and Group 3 participants will be asked to fasten their AFO(s) to a self-selected 'SSCT' tightness. For all groups, forces acting on the leg, within the proximal cuff, will be measured using wireless Loadpad sensors and forces acting on the foot will be measured using wireless Loadsol insoles. Testing will include collection of force data as participants sit quietly, stand quietly, and walk and completion of questionnaires.
Key Dates
- Start date
- Mar 1, 2024
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- No Intervention: NoCDOParticipants will complete study activities without wearing a CDO
- Experimental: SSCTParticipants will complete study activities while wearing a CDO fastened to their self-selected proximal cuff tightness
- Experimental: LooseParticipants will complete study activities while wearing a CDO fastened to a loose proximal cuff tightness
- Experimental: ModerateParticipants will complete study activities while wearing a CDO fastened to a moderate proximal cuff tightness
- Experimental: TightParticipants will complete study activities while wearing a CDO fastened to a tight proximal cuff tightness
Primary Outcome Measure
Proximal Cuff Force [ Time Frame: Baseline ]
Central Contacts
- Jason M Wilken, PT, PhD3193356857
- Kirsten M Anderson, PhD3193530431
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Iowa | Iowa City | Iowa | 52241 |
Find similar trials in Iowa City, IA
Related Studies
- Cell Free DNA in Cardiac SarcoidosisRecruiting · Nabeel Hamzeh · Iowa City, Iowa
- Hyperpolarized 129Xe MRI Lung Health CohortRecruiting · University of Kansas Medical Center · Chicago, Illinois
- A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4JRecruiting · Elpida Therapeutics SPC · San Francisco, California
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesPHASE3 · Recruiting · Pfizer · Birmingham, Alabama